Target intelligence / Profile preview

Retina and anterior neural fold homeobox protein 2 (RAX2)

Target
RAX2
Molecular classification
Transcription factor, Homeobox-containing protein
01

Overview

Retina and anterior neural fold homeobox protein 2 (RAX2) is a homeodomain-containing transcription factor predominantly expressed in the outer and inner nuclear layers of the retina. RAX2 regulates photoreceptor gene expression by acting as a coactivator, often forming complexes with other transcription factors such as CRX and NRL. It is critical for retinal development, particularly through its influence on the expression of key developmental genes like PAX6 and SOX2. Mutations in the RAX2 gene have been associated with inherited retinal disorders, including autosomal dominant cone-rod dystrophy (CORD11), autosomal recessive retinitis pigmentosa (ARRP), and age-related macular degeneration type 6 (ARMD6). RAX2 mutations disrupt normal photoreceptor cell function and differentiation, leading to progressive vision loss. To date, no approved drugs directly target RAX2.

Other names
QRXRAXL1MGC15631ARMD6CORD11Q50-type retinal homeobox proteinRetina and anterior neural fold homeobox-like protein 1RP95
02

Biological functions

Regulation of retinal developmentModulation of photoreceptor-specific gene expressionCell differentiation in the retinaRegulation of PAX6 and SOX2 expression (key eye development genes)Coactivation of transcription (especially partnering with CRX and NRL transcription factors)
03

Disease associations

Age-related macular degeneration (specifically type 6, ARMD6)Cone-rod dystrophy (CORD11)Retinitis pigmentosa (ARRP, autosomal recessive retinitis pigmentosa)
04

Safety considerations

Not applicable; RAX2 is not presently considered a direct therapeutic target, but its genetic mutations can implicate hereditary risk
05

Biomarkers

RAX2 genetic mutations as biomarkers for selected inherited retinal dystrophies (diagnosis/prognosis of ARMD6, CORD11)

Beyond the preview

Go deeper on Retina and anterior neural fold homeobox protein 2 (RAX2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retina and anterior neural fold homeobox protein 2 (RAX2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call